texte alternatif                                    

    Liste de publications de Christophe Moreno


      Parties d'ouvrages collectifs (3)
  1. 1. Moreno, C., & Trepo, E. (2013). Vitamin D deficiency and liver disease. In V. Arroyo & J. Rodés (Eds.), Advances in therapy of liver diseases. Spain: Ars Medica.
  2. 2. Moreno, C., & Degré, D. (2023). Diagnosis and staging of disease-severity in symptomatic alcoholic hepatitis. In Alcohol and Alcohol-related Diseases (pp. 1225-1231). Springer International Publishing. doi:10.1007/978-3-031-32483-3_65
  3. 3. Moreno, C., Degré, D., & Deltenre, P. (2023). Alcoholic hepatitis. In Comprehensive Guide to Hepatitis Advances (pp. 369-383). Elsevier. doi:10.1016/B978-0-323-98368-6.00012-4
    4.   Articles dans des revues avec comité de lecture (181)
  4. 1. Nault, J. C., Sritharan, N., Verset, G., Borbath, I., Lequoy, M., Allaire, M., Regnault, H., Colle, I., Orlent, H., Sinapi, I., Moreno, C., Larrey, E., Sidali, S., Hollande, C., Amaddeo, G., Pol, S., Nahon, P., Ganne-Carrié, N., Levy, V., Bloch-Queyrat, C., Trepo, E., & Bouattour, M. (2024). Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study. JHEP Reports, 6(11), 101192. doi:10.1016/j.jhepr.2024.101192
  5. 2. Marot, A., Henrion, J., Knebel, J. F., Trepo, E., Moreno, C., & Deltenre, P. (2023). A model for individualized prediction of liver-related death in outpatients with alcohol-associated cirrhosis. Hepatology Communications, 7(9). doi:10.1097/HC9.0000000000000229
  6. 3. Otero Sanchez, L., Zhan, C.-Y., Gomes Da Silveira Cauduro, C., Crenier, L., Njimi, H., Englebert, G., Putignano, A., Lepida, A., Degré, D., Boon, N., Gustot, T., Deltenre, P., Marot, A., Devière, J., Moreno, C., Cnop, M., & Trepo, E. (2023). A machine learning-based classification of adult-onset diabetes identifies patients at risk for liver-related complications. JHEP Reports.
  7. 4. Simão, A. L., Palma, C. S., Izquierdo-Sanchez, L., Putignano, A., Carvalho-Gomes, A., Posch, A., Zanaga, P., Girleanu, I., Henrique, M. M., Araújo, C., Degré, D., Gustot, T., Sahuco, I., Spagnolo, E., Carvalhana, S., Moura, M., Fernandes, D. A., Banales, J. J., Romero-Gómez, M., Trifan, A., Russo, F. P., Stauber, R., Berenguer, M., Moreno, C., Gonçalves, J., Cortez-Pinto, H., & Castro, R. R. (2023). Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease. JHEP Reports, 5(5), 100697. doi:10.1016/j.jhepr.2023.100697
  8. 5. Deltenre, P., Trepo, E., & Moreno, C. (2022). The concept of MAFLD gathers patients with distinct disease progression trajectories. Journal of hepatology. doi:10.1016/j.jhep.2022.11.009
  9. 6. Weichselbaum, L., Lepida, A., Marot, A., Trépo, E., Moreno, C., & Deltenre, P. (2022). Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: A systematic review with meta-analysis. United European gastroenterology journal, 10(8), 874-887. doi:10.1002/ueg2.12300
  10. 7. Ventura-Cots, M., Argemi, J., Jones, P. D., Lackner, C., El Hag, M., Abraldes, J. G., Alvarado, E., Clemente, A., Ravi, S., Alves, A., Alboraie, M., Altamirano, J., Barace, S., Bosques, F., Brown, R., Caballeria, J., Cabezas, J., Carvalhana, S., Cortez-Pinto, H., Costa, A., Degré, D., Fernandez-Carrillo, C., Ganne-Carrie, N., Garcia-Tsao, G., Genesca, J., Koskinas, J., Lanthier, N., Louvet, A., Lozano, J. J., Lucey, M. R., Masson, S., Mathurin, P., Mendez-Sanchez, N., Miquel, R., Moreno, C., Mounajjed, T., Odena, G., Kim, W., Sancho-Bru, P., Warren Sands, R., Szafranska, J., Verset, L., Schnabl, B., Sempoux, C., Shah, V. H., Shawcross, D. L., Stauber, R., Straub, B. K., Verna, E., Tiniakos, D., Trepo, E., Vargas, V., Villanueva, C., Woosley, J. T., Ziol, M., Mueller, S., Stärkel, P., & Bataller, R. (2022). Clinical, histological and molecular profiling of different stages of alcohol-related liver disease. Gut, 71(9), 1856-1866. doi:10.1136/gutjnl-2021-324295
  11. 8. Deltenre, P., Zanetto, A., Saltini, D., Moreno, C., & Schepis, F. (2022). The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions. Hepatology. doi:10.1002/hep.32596
  12. 9. Fujiwara, N., Trepo, E., Raman, I., Li, Q. Z., Degré, D., Gustot, T., Moreno, C., & Hoshida, Y. (2022). Plasma-Signature-Model for End-Stage Liver Disease Score to Predict Survival in Severe Alcoholic Hepatitis. Clinical gastroenterology and hepatology, 20(3), 651-657. doi:10.1016/j.cgh.2021.02.041
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Suivant >>